Aurora Daljit Singh
Insider CIK 1793971 · DERM Chief Scientific Affairs Off · NMRA See Remarks
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NMRA Neumora Therapeutics, Inc. | M Exercise deriv | 2026-08-21 | 2026-08-21 | 21,055 | — | $0 | 94,798 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | M Exercise deriv | 2026-08-21 | 2026-08-21 | 20,553 | — | $0 | 88,974 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | M Exercise | 2026-08-21 | 2026-08-21 | 21,055 | $0.72 | $15.2K | 21,055 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | S Sale | 2026-08-21 | 2026-08-21 | 21,055 | $1.60 | $33.7K | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | S Sale | 2026-08-21 | 2026-08-21 | 20,553 | $1.59 | $32.7K | 48,750 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | M Exercise | 2026-08-21 | 2026-08-21 | 20,553 | $0.72 | $14.8K | 69,303 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | M Exercise deriv | 2026-08-21 | 2026-08-21 | 21,055 | — | $0 | 94,798 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | M Exercise deriv | 2026-08-21 | 2026-08-21 | 20,553 | — | $0 | 88,974 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | S Sale | 2026-08-21 | 2026-08-21 | 21,055 | $1.60 | $33.6K | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | M Exercise | 2026-08-21 | 2026-08-21 | 21,055 | $0.72 | $15.2K | 21,055 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | S Sale | 2026-08-21 | 2026-08-21 | 20,553 | $1.59 | $32.8K | 48,750 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | M Exercise | 2026-08-21 | 2026-08-21 | 20,553 | $0.72 | $14.8K | 69,303 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | M Exercise deriv | 2026-08-20 | 2026-08-21 | 45,026 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | M Exercise deriv | 2026-08-20 | 2026-08-21 | 67,741 | — | $0 | 109,527 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2026-08-20 | 2026-08-21 | 200,000 | — | $0 | 200,000 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | M Exercise deriv | 2026-08-20 | 2026-08-21 | 21,685 | — | $0 | 115,853 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | S Sale | 2026-08-20 | 2026-08-21 | 67,741 | $1.51 | $102.3K | 48,750 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | M Exercise | 2026-08-20 | 2026-08-21 | 21,685 | $0.72 | $15.6K | 21,685 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | M Exercise | 2026-08-20 | 2026-08-21 | 45,026 | $0.72 | $32.4K | 66,711 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | S Sale | 2026-08-20 | 2026-08-21 | 66,711 | $1.51 | $100.7K | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | M Exercise | 2026-08-20 | 2026-08-21 | 67,741 | $0.72 | $48.8K | 116,491 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2026-08-20 | 2026-08-21 | 200,000 | — | $0 | 200,000 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | M Exercise deriv | 2026-08-20 | 2026-08-21 | 21,685 | — | $0 | 115,853 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | M Exercise deriv | 2026-08-20 | 2026-08-21 | 45,026 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | M Exercise deriv | 2026-08-20 | 2026-08-21 | 67,741 | — | $0 | 109,527 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | S Sale | 2026-08-20 | 2026-08-21 | 66,711 | $1.51 | $101.0K | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | M Exercise | 2026-08-20 | 2026-08-21 | 45,026 | $0.72 | $32.4K | 66,711 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | M Exercise | 2026-08-20 | 2026-08-21 | 21,685 | $0.72 | $15.6K | 21,685 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | S Sale | 2026-08-20 | 2026-08-21 | 67,741 | $1.51 | $102.6K | 48,750 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | M Exercise | 2026-08-20 | 2026-08-21 | 67,741 | $0.72 | $48.8K | 116,491 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | M Exercise deriv | 2026-08-19 | 2026-08-19 | 13,268 | — | $0 | 23,367 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | M Exercise deriv | 2026-08-19 | 2026-08-19 | 30,918 | — | $0 | 45,026 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | M Exercise deriv | 2026-08-19 | 2026-08-19 | 17,732 | — | $0 | 177,268 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | M Exercise | 2026-08-19 | 2026-08-19 | 13,268 | $0.72 | $9.6K | 62,018 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | M Exercise | 2026-08-19 | 2026-08-19 | 17,732 | $0.72 | $12.8K | 79,750 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | S Sale | 2026-08-19 | 2026-08-19 | 31,000 | $1.65 | $51.1K | 48,750 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | M Exercise | 2026-08-19 | 2026-08-19 | 30,918 | $0.72 | $22.3K | 30,918 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | S Sale | 2026-08-19 | 2026-08-19 | 30,918 | $1.65 | $51.0K | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | M Exercise deriv | 2026-08-19 | 2026-08-19 | 30,918 | — | $0 | 45,026 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | M Exercise deriv | 2026-08-19 | 2026-08-19 | 17,732 | — | $0 | 177,268 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | M Exercise deriv | 2026-08-19 | 2026-08-19 | 13,268 | — | $0 | 23,367 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | S Sale | 2026-08-19 | 2026-08-19 | 30,918 | $1.65 | $50.9K | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | M Exercise | 2026-08-19 | 2026-08-19 | 30,918 | $0.72 | $22.3K | 30,918 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | S Sale | 2026-08-19 | 2026-08-19 | 31,000 | $1.65 | $51.0K | 48,750 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | M Exercise | 2026-08-19 | 2026-08-19 | 17,732 | $0.72 | $12.8K | 79,750 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | M Exercise | 2026-08-19 | 2026-08-19 | 13,268 | $0.72 | $9.6K | 62,018 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | M Exercise deriv | 2026-08-18 | 2026-08-19 | 34,987 | — | $0 | 75,944 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | M Exercise deriv | 2026-08-18 | 2026-08-19 | 34,162 | — | $0 | 36,635 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | M Exercise | 2026-08-18 | 2026-08-19 | 34,162 | $0.72 | $24.6K | 82,912 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | S Sale | 2026-08-18 | 2026-08-19 | 34,162 | $1.58 | $54.0K | 48,750 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | M Exercise | 2026-08-18 | 2026-08-19 | 34,987 | $0.72 | $25.2K | 34,987 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | S Sale | 2026-08-18 | 2026-08-19 | 34,987 | $1.59 | $55.6K | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | M Exercise deriv | 2026-08-18 | 2026-08-19 | 34,987 | — | $0 | 75,944 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | M Exercise deriv | 2026-08-18 | 2026-08-19 | 34,162 | — | $0 | 36,635 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | S Sale | 2026-08-18 | 2026-08-19 | 34,987 | $1.59 | $55.5K | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | M Exercise | 2026-08-18 | 2026-08-19 | 34,987 | $0.72 | $25.2K | 34,987 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | S Sale | 2026-08-18 | 2026-08-19 | 34,162 | $1.58 | $54.1K | 48,750 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | M Exercise | 2026-08-18 | 2026-08-19 | 34,162 | $0.72 | $24.6K | 82,912 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | M Exercise deriv | 2026-08-17 | 2026-08-19 | 25,279 | — | $0 | 110,931 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | M Exercise deriv | 2026-08-17 | 2026-08-19 | 29,737 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | M Exercise deriv | 2026-08-17 | 2026-08-19 | 1 | — | $0 | 999,999 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | M Exercise deriv | 2026-08-17 | 2026-08-19 | 1,424 | — | $0 | 70,797 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | M Exercise deriv | 2026-08-17 | 2026-08-19 | 15,355 | — | $0 | 192,546 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | M Exercise deriv | 2026-08-17 | 2026-08-19 | 40,890 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | M Exercise | 2026-08-17 | 2026-08-19 | 1 | $0.72 | $1 | 140,440 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | S Sale | 2026-08-17 | 2026-08-19 | 34,020 | $1.49 | $50.7K | 48,750 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | S Sale | 2026-08-17 | 2026-08-19 | 57,670 | $1.51 | $87.1K | 82,770 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | M Exercise | 2026-08-17 | 2026-08-19 | 1,424 | $0.72 | $1.0K | 140,439 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | M Exercise | 2026-08-17 | 2026-08-19 | 25,279 | $0.72 | $18.2K | 25,279 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | M Exercise | 2026-08-17 | 2026-08-19 | 29,737 | $0.72 | $21.4K | 55,016 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | S Sale | 2026-08-17 | 2026-08-19 | 55,016 | $1.50 | $82.5K | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | M Exercise | 2026-08-17 | 2026-08-19 | 15,355 | $0.72 | $11.1K | 139,015 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | M Exercise | 2026-08-17 | 2026-08-19 | 40,890 | $0.72 | $29.4K | 123,660 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | M Exercise deriv | 2026-08-17 | 2026-08-19 | 29,737 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | M Exercise deriv | 2026-08-17 | 2026-08-19 | 25,279 | — | $0 | 110,931 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | M Exercise deriv | 2026-08-17 | 2026-08-19 | 1 | — | $0 | 999,999 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | M Exercise deriv | 2026-08-17 | 2026-08-19 | 1,424 | — | $0 | 70,797 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | M Exercise deriv | 2026-08-17 | 2026-08-19 | 15,355 | — | $0 | 192,546 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | M Exercise deriv | 2026-08-17 | 2026-08-19 | 40,890 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | S Sale | 2026-08-17 | 2026-08-19 | 55,016 | $1.50 | $82.8K | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | M Exercise | 2026-08-17 | 2026-08-19 | 29,737 | $0.72 | $21.4K | 55,016 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | M Exercise | 2026-08-17 | 2026-08-19 | 25,279 | $0.72 | $18.2K | 25,279 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | S Sale | 2026-08-17 | 2026-08-19 | 34,020 | $1.49 | $50.5K | 48,750 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | S Sale | 2026-08-17 | 2026-08-19 | 57,670 | $1.51 | $86.8K | 82,770 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | M Exercise | 2026-08-17 | 2026-08-19 | 1 | $0.72 | $1 | 140,440 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | M Exercise | 2026-08-17 | 2026-08-19 | 1,424 | $0.72 | $1.0K | 140,439 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | M Exercise | 2026-08-17 | 2026-08-19 | 15,355 | $0.72 | $11.1K | 139,015 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | M Exercise | 2026-08-17 | 2026-08-19 | 40,890 | $0.72 | $29.4K | 123,660 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | S Sale | 2026-02-17 | 2026-02-19 | 6,165 | $3.56 | $21.9K | 82,770 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2026-01-08 | 2026-01-09 | 750,000 | — | $0 | 750,000 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | S Sale | 2025-11-11 | 2025-11-13 | 114,703 | $2.68 | $307.4K | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2025-05-28 | 2025-05-30 | 136,210 | — | $0 | 136,210 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2025-05-28 | 2025-05-30 | 207,901 | — | $0 | 207,901 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2025-05-28 | 2025-05-30 | 72,221 | — | $0 | 72,221 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2025-05-28 | 2025-05-30 | 29,737 | — | $0 | 29,737 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2025-05-28 | 2025-05-30 | 195,000 | — | $0 | 195,000 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2025-05-28 | 2025-05-30 | 1,000,000 | — | $0 | 1,000,000 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | D To issuer deriv | 2025-05-28 | 2025-05-30 | 40,890 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | D To issuer deriv | 2025-05-28 | 2025-05-30 | 137,538 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | D To issuer deriv | 2025-05-28 | 2025-05-30 | 207,901 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | D To issuer deriv | 2025-05-28 | 2025-05-30 | 136,210 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | D To issuer deriv | 2025-05-28 | 2025-05-30 | 72,221 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | D To issuer deriv | 2025-05-28 | 2025-05-30 | 29,737 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | D To issuer deriv | 2025-05-28 | 2025-05-30 | 195,000 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | D To issuer deriv | 2025-05-28 | 2025-05-30 | 1,000,000 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2025-05-28 | 2025-05-30 | 40,890 | — | $0 | 40,890 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2025-05-28 | 2025-05-30 | 137,538 | — | $0 | 137,538 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | S Sale | 2025-02-18 | 2025-02-20 | 8,565 | $1.68 | $14.4K | 88,935 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | D To issuer deriv | 2025-02-13 | 2025-02-18 | 137,538 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | D To issuer deriv | 2025-02-13 | 2025-02-18 | 40,890 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2025-02-13 | 2025-02-18 | 1,000,000 | — | $0 | 1,000,000 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2025-02-13 | 2025-02-18 | 195,000 | — | $0 | 195,000 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2025-02-13 | 2025-02-18 | 29,737 | — | $0 | 29,737 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2025-02-13 | 2025-02-18 | 72,221 | — | $0 | 72,221 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2025-02-13 | 2025-02-18 | 136,210 | — | $0 | 136,210 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2025-02-13 | 2025-02-18 | 207,901 | — | $0 | 207,901 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | D To issuer deriv | 2025-02-13 | 2025-02-18 | 207,901 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | D To issuer deriv | 2025-02-13 | 2025-02-18 | 136,210 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | D To issuer deriv | 2025-02-13 | 2025-02-18 | 72,221 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | D To issuer deriv | 2025-02-13 | 2025-02-18 | 29,737 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | D To issuer deriv | 2025-02-13 | 2025-02-18 | 195,000 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2025-02-13 | 2025-02-18 | 137,538 | — | $0 | 137,538 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2025-02-13 | 2025-02-18 | 40,890 | — | $0 | 40,890 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | G Gift deriv | 2024-09-12 | 2024-09-13 | 137,538 | — | $0 | 137,538 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | G Gift deriv | 2024-09-12 | 2024-09-13 | 29,737 | — | $0 | 29,737 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | G Gift deriv | 2024-09-12 | 2024-09-13 | 29,737 | — | $0 | 72,221 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | G Gift deriv | 2024-09-12 | 2024-09-13 | 136,210 | — | $0 | 136,210 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | G Gift deriv | 2024-09-12 | 2024-09-13 | 137,538 | — | $0 | 40,890 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | G Gift deriv | 2024-09-12 | 2024-09-13 | 136,210 | — | $0 | 207,901 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | G Gift | 2024-04-22 | 2024-04-24 | 114,703 | — | $0 | 97,500 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award deriv | 2024-02-14 | 2024-02-16 | 195,000 | — | $0 | 195,000 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | A Award | 2024-02-14 | 2024-02-16 | 97,500 | — | $0 | 212,203 | SEC↗ |
| DERM Dermira, Inc. | D To issuer deriv | 2020-02-20 | 2020-02-24 | 7,040 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | D To issuer deriv | 2020-02-20 | 2020-02-24 | 708 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | D To issuer deriv | 2020-02-20 | 2020-02-24 | 67,500 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | D To issuer deriv | 2020-02-20 | 2020-02-24 | 2,814 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | D To issuer deriv | 2020-02-20 | 2020-02-24 | 574 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | D To issuer deriv | 2020-02-20 | 2020-02-24 | 6,250 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | D To issuer deriv | 2020-02-20 | 2020-02-24 | 28,000 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | D To issuer deriv | 2020-02-20 | 2020-02-24 | 50,000 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | D To issuer deriv | 2020-02-20 | 2020-02-24 | 10,000 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | D To issuer deriv | 2020-02-20 | 2020-02-24 | 22,500 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | D To issuer deriv | 2020-02-20 | 2020-02-24 | 11,500 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | D To issuer deriv | 2020-02-20 | 2020-02-24 | 28,130 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | D To issuer deriv | 2020-02-20 | 2020-02-24 | 6,000 | — | $0 | 0 | SEC↗ |
| DERM Dermira, Inc. | D To issuer | 2020-02-20 | 2020-02-24 | 30,089 | $18.75 | $564.2K | 0 | SEC↗ |
| DERM Dermira, Inc. | A Award deriv | 2019-11-11 | 2019-11-13 | 28,000 | — | $0 | 28,000 | SEC↗ |
| DERM Dermira, Inc. | A Award deriv | 2019-11-11 | 2019-11-13 | 6,000 | — | $0 | 6,000 | SEC↗ |